OVERWEIGHT FAMILIES UNAWARE & UNCONCERNED
Read More »Diabetes In Control
Issue 213 Item 2 Novo Strikes Deal For 52 Million Dollars For Possible Diabetes
Transition Therapeutics Inc. is on the verge of vaulting to the forefront of a breakthrough treatment for diabetes that’s as close to a cure as anything on the lab bench
Read More »ACE Inhibitors Cut Risk Of Death In Half For Those With Diabete
People with newly diagnosed type 2 diabetes could improve their odds of living longer and improve their heart health by taking these drugs, known as ACE inhibitors, a new study shows.
Read More »Issue 212 Item 9 Two New Noninvasive Blood Glucose Tests
One monitors changes in skin surface parameters and the other a breath analyzer.
Read More »Issue 214 Item 7 Key Discovery Found; Implications for New Approaches for Obesit
The discovery of a new receptor, called T-cadherin, could pave the way for new approaches to combating diabetes and obesity.
Read More »Issue 211 Item 9 Improved Sugar Levels Help Memory
A U.S./Scottish study found that improving blood sugar levels significantly improves working memory in people with Type 2 diabetes.
Read More »Issue 213 Item 8 Medical Professionals Must Set Example In War On Obesity
Obesity is a major public health concern in the United States and medical professionals are not exempt from the problem.
Read More »Issue 211 Item 3 FIRST OF NEW CLASS OF DRUGS FOR DIABETES SHOWN SUCCESSFUL
Exenatide reduces blood glucose, reduces weight and may restore beta cell function.
Read More »Issue 213 Item 1 Two For The Price Of One : Hypertension Drug Also Prevents Diab
Blood pressure drug reduces risk of diabetes by 23%.
Read More »Issue 210 Item 9 Jury Finds Rezulin Diabetes Drug Not Liable for Deaths
A jury in Los Angeles on Thursday found that a diabetes drug sold by Warner-Lambert, was not responsible for the deaths or illness of three plaintiffs.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.